Kristel Schorr is a partner with Foley & Lardner LLP. She is vice chair of the firm's Chemical, Biotechnology & Pharmaceutical Practice and a member of the Life Sciences Industry Team, and counsels life science clients regarding all aspects of intellectual property, including due diligence analyses, invalidity, non-infringement and freedom to operate opinions, IP portfolio management, patent prosecution, patent reexamination and interference proceedings.
Dr. Schorr's legal practice spans a number of technical areas, including immunology, molecular and cell biology, protein chemistry, gene therapy, oncology, small molecule pharmaceutical compositions and drug delivery systems, but her work often involves cell based therapeutics, and biologics such as antibodies and other large molecule receptor agonists and antagonists.
Dr. Schorr joined Foley in 2001 as a patent agent and law clerk, and later as an associate, after attending graduate school to study cancer biology. In particular, Dr. Schorr studied the regulation of apoptosis in mammary epithelial cells, and has authored and co-authored several scientific publications in the cancer field.
Dr. Schorr graduated from The George Washington University Law School (J.D., 2004), received her doctorate in medical physiology from the University of Maryland School of Medicine (Ph.D., 2000) and her undergraduate degree from The Pennsylvania State University (B.S., 1994). She is admitted to practice in Maryland, the District of Columbia, and before the U.S. Patent and Trademark Office.